Home > Boards > US Listed > Biotechs > Orthovita, Inc. (VITA)

8:17AM Orthovita provides 24-month data from Cortoss clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 439
Posts 25,572
Boards Moderated 4
Alias Born 09/11/06
160x600 placeholder
surf1944   Monday, 09/20/10 09:40:31 AM
Re: surf1944 post# 15
Post # of 30 
8:17AM Orthovita provides 24-month data from Cortoss clinical pilot studies in Vertebroplasty and Kyphoplasty (VITA) 1.85 : Co announces publication of "Clinical Experience Using Cortoss for Treating Vertebral Compression Fractures with Vertebroplasty and Kyphoplasty" in the 9/15/10 edition of Spine. The paper concludes that based on the results of these pilot studies: Cortoss is safe and effective in treating osteoporotic VCFs using either vertebroplasty or kyphoplasty and VCF pain relief and functional restoration achieved with Cortoss is comparable to the results reported in the literature for VCFs treated with polymethylmethacrylate.


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist